Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.55
-$0.03-0.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.28% | 21.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.28% | 21.18% | |||
| Cost of Revenue | -12.46% | 19.75% | |||
| Gross Profit | 1.17% | 21.89% | |||
| SG&A Expenses | 0.15% | 0.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.57% | 1.14% | |||
| Operating Income | -8.65% | 9.94% | |||
| Income Before Tax | -4.76% | 46.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.76% | 46.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.76% | 46.32% | |||
| EBIT | -8.65% | 9.94% | |||
| EBITDA | -8.65% | 9.93% | |||
| EPS Basic | -4.34% | 53.25% | |||
| Normalized Basic EPS | -6.67% | 55.23% | |||
| EPS Diluted | -4.34% | 53.25% | |||
| Normalized Diluted EPS | -6.67% | 55.23% | |||
| Average Basic Shares Outstanding | 0.40% | 14.83% | |||
| Average Diluted Shares Outstanding | 0.40% | 14.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||